Applied Clinical Trials
Survey collects thoughts from industry professionals on the current and future impact of big data in clinical trials.
In October, SCORR Marketing and Applied Clinical Trials surveyed our audience on big data. As results indicate at right, most respondents agree that big data is important to the clinical research enterprise. However, when asked if it was important in their own companies, those numbers were noticeably higher in the “slightly” to “not at all” categories.
Regardless, the survey did uncover some big data trends. For example, the majority of respondents are using medical records, biomarker and registry data as sources, in that order. Of those, the medical record data is rated the most important by 48% of the respondents.
As for the future uses and impact of big data in clinical trials, some areas are brighter than others. One-third of respondents believe the EHR will be the data of record for all new patient data, and an additional one-fourth believe that predictive modeling will be used to inform preclinical and translational research.
Conversely, only 4% of respondents think patient recruitment rates will be improved in five years if they used big data. Please download the free report here.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.